A LONGITUDINAL PROSPECTIVE-STUDY OF CYTOMEGALOVIRUS-PP65 ANTIGENEMIA IN RENAL-TRANSPLANT RECIPIENTS

被引：5

作者：

BEIN, G

BITSCH, A

HOYER, J

STEINHOFF, J

FRICKE, L

MACHNIK, H

DENNIN, R

KIRCHNER, H

机构：

[1] Institute of Immunology and Transfusion Medicine, University of Lübeck Medical School, Lübeck, W-2400

[2] Department of Surgery, University of Lübeck Medical School, Lübeck, W-2400

[3] Department of Internal Medicine, University of Lübeck Medical School, Lübeck, W-2400

[4] Institute of Medical Microbiology, University of Lübeck Medical School, Lübeck, W-2400

来源：

TRANSPLANT INTERNATIONAL | 1993年 / 6卷 / 04期

关键词：

CMV ANTIGENEMIA; RENAL TRANSPLANTATION; PP65; ANTIGEN; CMV;

D O I：

10.1007/BF00337097

中图分类号：

R61 [外科手术学];

学科分类号：

摘要：

Cytomegalovirus (CMV)-encoded pp65 antigen in peripheral blood leukocytes (CMV antigenemia) was investigated in 1017 serial samples from 64 patients for 16 weeks after renal transplantation in a prospective study. In 110 samples from 24 patients, at least one antigen-positive leukocyte was identified. The median number of stained cells was 4 (range 1-1000) per 4 x 10(5) leukocytes. Twenty-one of 24 patients with serological signs of an active CMV infection were antigen-positive (sensitivity 87.5 %), whereas 3 patients with antigenemia did not show serological signs of infection during the observation period (specificity 92.5 %). Positive results were obtained 19 days (median) before serological response and 9 days (median) before the onset of CMV syndrome. The sensitivity in defining a CMV syndrome was 100 % (n = 8). In all patients who presented with CMV syndrome, antigenemia was present prior to the onset of symptoms or on the same day. In contrast, serological monitoring rendered the diagnosis of CMV infection possible at the onset of clinical symptoms in only two of eight patients. We conclude that (1) insufficient results obtained with the CMV antigenemia assay by other investigators are mainly due to technical problems that can easily be overcome by the protocol presented and (2) the detection of CMV pp65 antigen in peripheral blood leukocytes is an excellent tool for rapid and early diagnosis of CMV infection.

引用

页码：185 / 190

页数：6

共 20 条

[1] Balfour H.H., Chace B.A., Stapleton J.T., Simmons R.L., Fryd D.S., A randomized, placebo-controlled trial of oral acyclovir for the prevention of cytomegalovirus disease in recipients of renal allografts, N Engl J Med, 320, pp. 1381-1387, (1989)
[2] Bein G., Bitsch A., Hoyer J., Kirchner H., The detection of human cytomegalovirus immediate early antigen in peripheral blood leucocytes, J Immunol Methods, 137, pp. 175-180, (1991)
[3] van den Berg A.P., van der Bij W., van Son W.J., Anema J., van der Giessen M., Schirm J., Tegzess A.M., The T.H., Cytomegalovirus antigenemia as a useful marker of symptomatic cytomegalovirus infection after renal transplantation —a report of 130 consecutive patients, Transplantation, 48, pp. 991-995, (1989)
[4] van den Berg A.P., Klompmaker I.J., Haagsma E.B., Scholten-Sampson A., Bijleveld C.M., Schirm J., van der Giessen M., Slooff M.J., The T.H., Antigenemia in the diagnosis and monitoring of active cytomegalovirus infection after liver transplantation, J Infect Dis, 164, pp. 265-270, (1991)
[5] van der Bij W., Torensma R., van Son W.J., Anema J., Schirm J., Tegzess A.M., The T.H., Rapid immunodiagnosis of active cytomegalovirus infection by monoclonal antibody staining of blood leucocytes, J Med Virol, 25, pp. 179-188, (1988)
[6] Bitsch A., Kirchner H., Dupke R., Bein G., Failure to detect human cytomegalovirus DNA in peripheral blood leukocytes of healthy blood donors by the polymerase chain reaction, Transfusion, 32, pp. 612-617, (1992)
[7] Boland G.J., de Gast G.C., Hene R.J., Jambroes G., Donckerwolcke R., The T.H., Mudde G.C., Early detection of active cytomegalovirus (CMV) infection after heart and kidney transplantation by testing for immediate early antigenemia and influence of cellular immunity on the occurrence of CMV infection, J Clin Microbiol, 28, pp. 2069-2075, (1990)
[8] Bosch F.H., Hoitsma A.J., Janssen H.P., van Loon A.M., Koene R.A.P., Cytomegalovirus infection and disease in renal transplant patients treated with cyclosporin. A prospective study, Transpl Int, 2, pp. 92-95, (1989)
[9] Chou S., Newer methods for diagnosis of cytomegalovirus infection, Clinical Infectious Diseases, 12, pp. 727-736, (1990)
[10] Gerna G., Zipeto D., Parea M., Revello M.G., Silini E., Percivalle E., Zavattoni M., Grossi P., Milanesi G., Monitoring of human cytomegalovirus infections and ganciclovir treatment in heart transplant recipients by determination of viremia, antigenemia, and DNAemia, J Infect Dis, 164, pp. 488-498, (1991)

← 1 2 →